User: Guest  Login
Title:

Pharmacological treatment of early multiple sclerosis.

Document type:
Journal Article; Review; Review
Author(s):
Stüve, O; Bennett, JL; Hemmer, B; Wiendl, H; Racke, MK; Bar-Or, A; Hu, W; Zivadinov, R; Weber, MS; Zamvil, SS; Pacheco, MF; Menge, T; Hartung, HP; Kieseier, BC; Frohman, EM
Abstract:
Currently, six medications are approved by the US FDA for the treatment of relapsing forms of multiple sclerosis (MS). In contrast, no pharmacological agent has proved to be effective in patients with secondary-progressive MS without relapses, or in patients with primary-progressive MS. One of the principal issues concerning an optimal pharmacotherapy for relapsing forms of MS is the optimal time of treatment initiation. There is now an almost universal consensus among MS experts that many patie...     »
Journal title abbreviation:
Drugs
Year:
2008
Journal volume:
68
Journal issue:
1
Pages contribution:
73-83
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/18081373
Print-ISSN:
0012-6667
TUM Institution:
Neurologische Klinik und Poliklinik
 BibTeX